Elizabeth Trehu
- Molecular Biology top 10%
- Oncology top 5%
- Pathology and Forensic Medicine top 2%
- Immunology top 5%
- Hematology top 2%
- Co-authors
- Herbert TilgJ W MierMB AtkinsCA DinarelloDavid P. SchenkeinDixie EsseltineJames R. WrightCraig H. Moskowitz
- Topics
- Chronic Lymphocytic Leukemia Research (7 papers)Ubiquitin and proteasome pathways (7 papers)Lymphoma Diagnosis and Treatment (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Elizabeth Trehu
33 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 914
- Oncology 752
- Pathology and Forensic Medicine 657
- Immunology 529
- Hematology 501
Countries citing papers authored by Elizabeth Trehu
This map shows the geographic impact of Elizabeth Trehu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Trehu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Trehu more than expected).
Fields of papers citing papers by Elizabeth Trehu
This network shows the impact of papers produced by Elizabeth Trehu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Trehu. The network helps show where Elizabeth Trehu may publish in the future.
Co-authorship network of co-authors of Elizabeth Trehu
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Trehu. A scholar is included among the top collaborators of Elizabeth Trehu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Trehu. Elizabeth Trehu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 77 | |
| 3 | 32 | |
| 4 | 1 | |
| 5 | 35 | |
| 6 | 6 | |
| 7 | 93 | |
| 8 | 82 | |
| 9 | 4 | |
| 10 | 2 | |
| 11 | 416 | |
| 12 | 7 | |
| 13 | 36 | |
| 14 | Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera. | 14 |
| 15 | 36 | |
| 16 | 18 | |
| 17 | 25 | |
| 18 | 14 | |
| 19 | 7 | |
| 20 | 7 |
About Elizabeth Trehu
Elizabeth Trehu is a scholar working on Genetics, Hematology and Immunology, having authored 33 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Ubiquitin and proteasome pathways (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Genetics (491 citations), Hematology (501 citations) and Pathology and Forensic Medicine (657 citations). Elizabeth Trehu has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Herbert Tilg, J W Mier, MB Atkins, CA Dinarello, David P. Schenkein, Dixie Esseltine, James R. Wright, Craig H. Moskowitz, Paul A. Hamlin and Barbara MacGregor‐Cortelli. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.